I developed several microfluidic and lab-on-a-chip devices and software as powerful tools to overcome these challenges.
This includes;
1. A microfluidic device for localized microinjection and heart monitoring of intact Drosophila, (fruit fly) larvae, enabling studies not possible before.
2. A software for quantification of heartbeat parameters of intact Drosophila and Zebrafish larvae, enabling measurement of up to eight heartbeat parameters.
3. A microfluidic device for measuring Drosophila larval hemolymph viscosity.
4. An acoustofluidic device for rotational manipulation of Drosophila embryos.
- Larvae and embryos expressing GFP in their pericardial cells and membrane cardiomyocytes.
- Larvae and embryos expressing MTF-1 in their membrane cardiomyocytes.
- Larvae and embryos expressing the SARS-CoV-2 ORF3a protein in their pericardial cells and membrane cardiomyocytes.